Trial intelligence / Profile preview

Microdosing LSD for adults with ADHD

NL-OMON61114Phase 2Withdrawn

Sponsor
Maastricht University
Start
Jun 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lysergide, sponsored by Maastricht University. Planned start Jun 2026; status: withdrawn.

02

Drugs

Lysergide

Beyond the preview

Go deeper on NL-OMON61114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON61114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call